West syndrome with periventricular leukomalacia: ten-year clinical study

Radenka Kuzmanić-Samija1, Biserka Resić, Maja Tomasović

  • 1Pediatrics Clinic, University Hospital Split, School of Medicine, University of Split, Croatia. dada.samija@st.htnet.hr

Insights

Periventricular leukomalacia (PVL) and West syndrome (WS) in infants are linked to significant neurodevelopmental deficits. Brain MRI reveals reduced gray matter and delayed myelination, explaining cognitive impairments in affected premature infants.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Developmental Neuroscience

Background:

  • Periventricular leukomalacia (PVL) is a common form of brain injury in premature infants.
  • West syndrome (WS) is a severe form of epilepsy typically presenting in infancy.
  • The co-occurrence of PVL and WS presents significant challenges in understanding neurodevelopmental outcomes.

Purpose of the Study:

  • To evaluate magnetic resonance imaging (MRI) findings in infants with both PVL and WS.
  • To determine the neurodevelopmental outcomes in children diagnosed with both PVL and WS.
  • To explore the relationship between neuroimaging findings and cognitive deficits in this population.

Main Methods:

  • Retrospective analysis of 37 infants with diagnosed PVL.
  • Brain MRI and ultrasound imaging were utilized for neuroimaging assessment.
  • PVL and WS were categorized using established classification systems (De Vries and ILAE 1989, respectively).

Main Results:

  • The most frequent interictal abnormality observed was hypsarrhythmia.
  • A significant majority of patients (all but two) exhibited delayed development and varying degrees of intellectual disability.
  • Characteristic MRI findings included reduced cerebral cortical gray matter volume, decreased brain myelin volume, and delayed myelination.

Conclusions:

  • Neuroimaging findings in infants with PVL and WS, such as reduced gray matter and delayed myelination, correlate with intellectual and cognitive deficits.
  • These findings help explain the anatomical basis for neurodevelopmental impairments in premature infants with PVL and WS.
  • Early identification and characterization of these neuroimaging markers are crucial for predicting outcomes in affected infants.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...